Skip to main content

Walleye Capital LLC

Position in REPL — Replimune Group, Inc.

CIK 1758720 NEW YORK, NY

Position in REPL

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$547,678
+$547,678 QoQ
Shares Held
71,592
Ownership
0.085%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2023
7 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in REPL Over Time

Shares Held

Position Value (USD)

Derivatives in REPL

reported options exposure · as of Dec 31, 2025
CallValue
$837,864
CallShares
86,200
PutValue
$163,296
PutShares
16,800

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Walleye Capital LLC holds $278,334,962 across 104 Biotechnology names. REPL ranks #70 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in REPL

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $547,678 71,592
2025-12-31 $163,296 16,800
2025-12-31 $837,864 86,200
2025-09-30 $252,238 60,200
2025-09-30 $11,732 2,800
2025-09-30 $88,220 21,055
2024-06-30 $447,786 49,754
2024-03-31 $247,150 30,251
2024-03-31 $24,510 3,000
2023-12-31 $253,388 30,058
2023-12-31 $8,430 1,000
2023-12-31 $90,201 10,700
2023-06-30 $1,176,394 50,663